Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Recursion Pharmaceuticals, Inc. (RXRX)  
$9.70 0.33 (3.52%) as of 4:30 Tue 6/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 208,280,000
Market Cap: 2.02(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.09 - $15.86
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,693,990
Total Buy Value $0 $0 $0 $12,897,789
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 27
Total Shares Sold 564,413 1,082,628 2,172,338 3,134,404
Total Sell Value $4,963,885 $10,611,422 $21,336,553 $29,945,301
Total People Sold 4 6 8 8
Total Sell Transactions 23 46 96 154
End Date 2024-03-21 2023-12-19 2023-06-20 2022-06-20

   
Records found: 645
  Page 21 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gibson Christopher Chief Executive Officer   •       •      –    2022-04-05 4 AS $7.31 $18,284 I/I (2,500) 0 82%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-04-05 4 A $0.00 $0 I/I 2,500 1,000     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-04-05 4 AS $7.31 $256,234 D/D (34,472) 262,058 82%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-04-05 4 A $0.00 $0 D/D 18,500 280,558     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-04-05 4 OE $2.48 $109,145 D/D 44,010 278,030     -
   Burrell Terry-Ann Director   –       •      –    2022-04-01 4 A $0.00 $0 D/D 1,788 136,373     -
   Borgeson Blake Director   –       •      –    2022-04-01 4 A $0.00 $0 D/D 1,300 7,652,446     -
   Bogue Zachary Director   –       •       •   2022-04-01 4 A $0.00 $0 D/D 1,382 2,752     -
   Chavez R Martin Phd Director   –       •      –    2022-04-01 4 A $0.00 $0 D/D 2,438 11,107     -
   Li Dean Y Director   –       •      –    2022-04-01 4 A $0.00 $0 D/D 1,544 599,466     -
   Doyle Ramona Chief Medical Officer   •       –      –    2022-03-31 4 OE $2.48 $22,499 D/D 9,072 121,942     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-15 4 S $6.08 $37,407 D/D (6,150) 234,020 -26%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-15 4 A $0.00 $0 D/D 6,150 240,170     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-14 4 S $6.28 $1,444,814 D/D (230,000) 234,020 -27%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-14 4 A $0.00 $0 D/D 230,000 464,020     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-11 4 S $6.95 $694,580 D/D (100,000) 234,020 -26%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-11 4 A $0.00 $0 D/D 100,000 334,020     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-07 4 S $7.30 $2,188,950 D/D (300,000) 234,020 -20%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-03-07 4 A $0.00 $0 D/D 300,000 534,020     -
   Larson Tina Marriott President and COO   •       –      –    2022-03-04 4 OE $1.06 $62,010 D/D 58,500 208,018     -
   Doyle Ramona Chief Medical Officer   •       –      –    2022-02-28 4 OE $2.48 $38,750 D/D 15,625 112,870     -
   Gibson Christopher Chief Executive Officer   •       •      –    2022-02-22 4 S $10.22 $1,021,540 D/D (100,000) 234,020 17%     
   Gibson Christopher Chief Executive Officer   •       •      –    2022-02-22 4 A $0.00 $0 D/D 100,000 334,020     -
   Larson Tina Marriott President and COO   •       –      –    2022-02-18 4 OE $1.06 $16,960 D/D 16,000 149,518     -
   Larson Tina Marriott President and COO   •       –      –    2022-02-14 4 OE $1.06 $4,240 D/D 4,000 133,518     -
  645 Records found
  Previous  20  21  22  23  24  25  26   
  Page 21 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us